648: Antiphospholipid antibody screening following pregnancy with iugr or preeclampsia: a cost-effectiveness analysis

Post-delivery oxidative stress in women with preeclampsia or IUGR.

AIM To compare oxidative stress in patients with preeclampsia (PE) or intrauterine growth restriction (IUGR) vs. normal pregnancy (controls) during 48 h after delivery. STUDY DESIGN Women with singleton pregnancies were recruited immediately after delivery (gestational age >26.0 weeks). Women with PE or IUGR were matched with healthy controls by age, BMI, gestational age and delivery mode. Ve...

Cervical cancer screening with AMIGAS: a cost-effectiveness analysis.

BACKGROUND Hispanic women have a higher incidence of cervical cancer than all other races and ethnicities. In Hispanic subgroups, Mexican American women were among the least likely to have received cervical cancer screening. In a recent RCT, Ayudando a las Mujeres con Información, Guia, y Amor para su Salud (AMIGAS) was shown to increase cervical cancer screening rates among women of Mexican de...

HIV Screening via Fourth-Generation Antigen-Antibody or Nucleic Acid Amplification Test: A Cost-Effectiveness Analysis Supporting Information

Cost effectiveness of type 2 diabetes screening: A systematic review

Background: Although studies reported diabetes mellitus screening cost effective, the mass screening for type2 diabetes remains controversial. In this study we reviewed the recently evidence about the cost effectiveness of mass screening systematically.   Methods: We reviewed the MEDLINE, Scopus, Web of Science (WOS), and Cochrane library databases by MeSH terms to identify relevan...

The investigation of relationship between preeclampsia and antiphospholipid antibody syndrome

Aim. The aim of this study was evaluate the relationship between preeclampsia and antiphospholipid antibodies. Methods. A total of 116 pregnant women between 20th and 40th weeks of gestation admitted to our department were investigated. 63 of them were allocated our preeclampsia group and 53 of them were allocated our control group. Lupus anticoagulant, anticardiolipin antibodies (IG G ve M) an...